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1. Introduction
Amlodipine besylate belongs 
to a group of blockers of calcium 
channels, derivatives of 1,4-dihy-
dropyridine, is used to treatment 
of arterial hypertension and va-
sospastic forms of angina pectoris 
[1, 2]. Amlodipine reduces pe-
ripheral and coronary resistance, 
improves coronary blood flow, 
reduces intracellular overload 
with calcium, suppresses platelet 
aggregation. Amlodipine in mod-
ern hypertension therapy is wide-
ly used in conjunction with the 
preparations of the main groups 
of antihypertensive drugs: perin-
dopril [3], ramipril and lisinopril 
[4], indapamide [5]. When am-
lodipine is used, there are possible 
side effects: arterial hypotension, 
tachycardia, headache, nausea, 
dizziness, visual impairment, and 
depression. The main manifesta-
tions of amlodipine overdose are 
hyperglycemia, metabolic acido-
sis, electrolyte imbalance, sinus 
bradycardia, collapse [1]. Accord-
ing to the literature sources, am-
lodipine in case of overdose can 
provoke the development of breast 
cancer [6], cause ischemia of the 
optic nerve [7]. Deadly poisoning 
with amlodipine may accompany 
drug overdoses or suicidal cases. 
Fatal doses for children and adults 
range from 0,9 to 4,1 mg/kg [8, 9]. 
One of the important stages 
in the forensic toxicological ex-
amination is the choice of corpse 
organs to investigate them for 
the presence of substances that 
could be the cause of poisoning. 
The right choice of organs of a 
deceased person makes it possi-
ble not to lose toxic substances, 
to carry out screening, identifi-
cation and quantitative determi-
nation of them. The algorithm of 
investigation of biological objects for the presence of a toxic sub-
stance involves several stages: the development and validation of 
identification and quantification methods for the test substance 
on model solutions, the application of developed techniques for 
studying the model mixes of toxic substances and biological ma-
terial, approbation of techniques on organs of poisoned animals 
and introduction of the algorithm research on human body 
material. The last stage is performed in the forensic-toxicolog-
ical department of the bureau of forensic medical examination 
of the city or region by forensic experts. In literature there are 
limited data on the distribution of amlodipine in the poisoned 
animal bodies that do not have a systematic character [10].
The aim of the investigation is the study of the distribution 
of amlodipine in organs of poisoned animals, using developed 
highly sensitive and selective 
techniques for analysis of am-
lodipine in biological objects.
2. Materials and methods
For the study, model mix-
tures of 10,0 g of chopped liver 
of animal origin and 1,0 ml of 
aqueous solution of amlodipine 
besylate containing 1000,0 μg of 
the drug were thoroughly mixed 
and left for a day. Amlodipine 
was extracted from biological 
fluids using 5,0 ml of blood and 
10,0 ml of urine with addition 
of 1,0 ml of aqueous solution of 
amlodipine besylate containing 
500,0 μg of the drug, stirred and 
left for a day. Control experi-
ments were put in parallel.
Extraction of amlodipine 
from a biological material us-
ing methanol and acetonitrile 
(2:3) was carried out according 
to the developed method [10]: 
10 % solution of chloride acid 
to pH 2,0–3,0 and a mixture of 
methanol and acetonitrile (2:3) 
in a volume of 10,0 ml, was thor-
oughly mixed. The vials with a 
mixture were shaken on an au-
tomatic shaker for 10 minutes, 
centrifuged for 5 minutes at 
2500 rpm. The liquid over sed-
iment was separated and the 
extraction was repeated by two 
portions of eluent of 10,0 ml.
Extraction purification of 
the extract from the liver tis-
sue was performed according 
to the procedure: the combined 
extracts were filtered through 
a paper filter in a separating 
funnel containing 50,0 ml of 
2,5 % aqueous sodium sulfate 
solution, were acidified with 
10 % acid chloride solution to 
pH 2,0–3,0 (according to the 
universal indicator) and the 
biogenic impurities were extracted twice with portions of 
diethyl ether of 10,0 ml. The ether layers were separated and 
not further investigated. The water-methanol-acetonitrile 
solution was alkalized with 20 % solution of sodium hydrox-
ide to pH 7,0–7,5 and amlodipine-base was extracted three 
times with portions of chloroform of 10,0 ml. The chloro-
form extracts were combined and centrifuged for 10 minu- 
tes at 5000 rpm for the destruction of stable emulsions. 
Chloroform extracts were filtered through a paper filter 
(“red tape”) with 1,0 g sodium sulfate anhydrous, were evap-
orated to a dry residue which was dissolved in methanol, 
and then quantitatively was transferred to 5,0 ml volumetric 
f lask. The volume was brought to the mark with methanol 
and examined by thin layer chromatography-method (TLC).
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The aim of the investigation is the study of the distribution 
of amlodipine in organs of poisoned animals, using devel-
oped highly sensitive and selective techniques for the analy-
sis of amlodipine in biological objects.
Materials and methods. To study the distribution of amlodip-
ine in organs of poisoned animals, rats weighing 200–250 g 
were used. Amlodipine besylate solution was administered to 
rats using a probe in the stomach from the calculation of 
70,0 mg/kg, after 3 hours rats were decapitated. For the study 
blood, urine, heart, liver, kidneys, lungs, stomach and intes-
tine with contents and spleen were taken. Control experi-
ments were delivered with the appropriate organs in parallel. 
Extraction of the substance was carried out with a mixture 
of methanol and acetonitrile (2: 3), purification was car-
ried out by extraction of impurities with diethyl ether at pH 
2,0–3,0 and TLC-method. Amlodipine was identified in bio-
genic extracts by the TLC-method in three systems of mobile 
solvents. The substance content was determined by spectro-
photometry methods in the UV region of the spectrum.
Results and discussion. It is established that the highest amount 
of amlodipine was found in the stomach and intestine with the 
content, which is typical for acute poisoning. Less amount of 
amlodipine is found in the liver, kidneys and urine – organs 
and liquids that provide active detoxification of the body. 
According to the results of the research, it was found that in 
case of lethal poisoning, amlodipine for forensic toxicological 
studies should be carried out in urine, stomach with contents, 
intestine with contents, liver, spleen and kidneys.
Conclusions. The distribution of amlodipine in organs of 
poisoned animals with oral administration was studied. It 
is established that in case of lethal poisoning with amlodip-
ine, for forensic-toxicological research it is necessary to be 
conducted in urine, stomach with contents, intestine with 
contents, spleen and kidneys. The developed methods can 
be proposed for introduction into the practice of the Bureau 
of Forensic Medical Examination, toxicological centers.
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biological fluids of poisoned rats, forensic toxicological ex-
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TLC-purification and identification of amlodipine in the 
extracts were carried out using the following procedure: 1,0 ml 
of amlodipine methanol solution, which corresponded to 
2,0 g of biological material, was evaporated to 0,3–0,5 ml 
and was applied in the form of a strip of length 2 cm on the 
starting line of the chromatographic plate for high-perfor-
mance thin-layer chromatography (production of Estonia, sili-
cagel KSKG, fraction 5–20 microns, thickness of the layer 130± 
±25 microns, plate size 20×20 cm). At a distance of 2 cm from 
the strip, a standard methanolic solution (20,0 μg/ml) of am-
lodipine was applied to the spot. At a distance of 2 cm from 
the point that corresponded to the witness, the extracted from 
the control sample, as obtained above, was applied. Chroma-
tography was carried out in a chamber of a volume of 500 cm3, 
in which 50,0 ml of a system of organic solvents – chloroform – 
methanol (9:1) was introduced, followed by saturation of the 
chamber in solvent pairs for at least 30 minutes. The length of 
the run of the front of the moving phase is 7 cm. The chromato-
graphic plate was dried at room temperature, after which its 
part, where the witness and the extract from the control sample 
were located, were treated with the most sensitive reagent of 
Dragendorff for Munie (sensitivity of the reagent – 3,0–5,0 μg 
of the substance in the sample); Rf amlodipine=0,51–0,53, the im-
purities were located on the line of start or on the finish line.
In order to confirm the results of the identification of am-
lodipine by TLC-method, were used chromatographic plates for 
high-performance thin-layer chromatography, a system of mo-
bile solvents – chloroform-acetone-isopropanol – 25 % solution 
of ammonium hydroxide (7:7:7:2), Rf amlodipine=0,55–0,57 and 
chloroform – acetone – 25 % solution of ammonium hydroxide 
(15:15:1), Rf amlodipine=0,49-0,51.
At the level of finding the spot of a standard solution of 
the amlodipine from part of the chromatographic plate, which 
was not treated by the reagent of Dragendorff for Munie, was 
removed the layer of sorbent with an area of 4–5 cm². The layer 
of sorbent was transferred to the filter. The amlodipine-base 
was eluted three times with portions of methanol of 5,0 ml. The 
resulting solution was filtered through a filter (“red tape”) and 
was evaporated to a dry residue. The dry residue was dissolved 
in chloroform, and then quantitatively was transferred to a vol-
umetric flask of 10,0 ml, was brought to the mark with a solvent. 
Chloroform solution was used for quantitative determination by 
spectrophotometry in the UV region of the spectrum using the 
techniques developed.
The quantitative determination of amlodipine by spectro-
photometry in the UV region of the spectrum was carried out 
under the conditions [11]: the optical density of the chloroform 
solution obtained after purification was determined on a spec-
trophotometer SF-46, cell thickness 10 mm; λmax=365±2 nm. 
The solution, which was obtained from a control experiment, 
was used as a solution for comparison. The concentration of 
amlodipine in a solution (C, μg/ml) was calculated from the 
calibration graph or by the linear equation of the optical den-
sity and its concentration: A=0,0329+0,0225 C, where A is the 
optical density of the chloroform solution of amlodipine; C is 
the concentration of amlodipine solution, μg/ml. The interval 
of the linearity of the calibration graph is 5,0–35,0 μg/ml, the 
lower limit of determination is 5,0 μg/ml, the correlation coef-
ficient is 0,9997. The relative uncertainty of the mean result in 
the analysis of amlodipine in model solutions was ε=±1,64 %. 
It is established that following the methods of extraction of 
amlodipine with a mixture of methanol and acetonitrile (2:3), 
purification by diethyl ether extraction and TLC-method, 
TLC-method identification and quantitative determination of 
amlodipine content by spectrophotometry in the UV region 
of the spectrum 76,21–84,07 % amlodipine (ε=±4,91 %) can be 
determined in the liver tissue.
Extraction of amlodipine from blood was carried out ac-
cording to the developed method: to the mixture was added 
5,0 ml of purified water and 10,0 ml of 10 % solution of acid 
chloride, left for 2 hours, periodically stirred. The mixture 
was centrifuged for 5 minutes (5000 rpm), the centrifuge was 
separated. Extraction of the substance from the precipitate was 
repeated using the above experimental techniques.
For extraction purification from impurities, the centrifuges 
(pH 2,0–3,0) were combined, transferred to a separating funnel 
and impurities were extracted twice with portions of diethyl 
ether of 5,0 ml. The ether layers were separated and not further 
investigated. The acidic water layer was alkalized by a 20 % 
solution of sodium hydroxide to pH 7,0–7,5. The amlodip-
ine-base was extracted three times with portions of chloroform 
of 5,0 ml. Purification and identification by TLC-method, quan-
titative determination of the content of amlodipine by spectro-
photometry in the UV region of the spectrum was carried out 
using the above methods.
For extraction of amlodipine from urine the mixture was 
acidified with 10 % solution of acid chloride to pH 2,0–3,0. 
The following stages of extraction purification, identification 
and quantitative determination of the content of amlodipine 
were performed using methods of analysis of amlodipine in the 
blood. It is established that following the methods of extraction 
of amlodipine from biological fluids it is possible to deter-
mine in the blood – 48,66–53,07 % amlodipine (ε=±4,32 %), 
in urine – 75,37–80,38 % amlodipine (ε=±3,21 %).
3. Results
For the study of the distribution of amlodipine in organs 
of poisoned animals, rats weighing 200–250 g that did not 
receive food during the day were used. Amlodipine besylate 
solution was administered to rats using a probe in the stomach 
from the calculation of 70,0 mg/kg (LD50 was 40–100 mg/kg), 
after 3 hours rats were decapitated. For the study blood, 
urine, heart, liver, kidneys, lungs, stomach and intestine with 
contents and spleen were taken. Control experiments were 
delivered with the appropriate organs in parallel. The stages 
of extraction, purification, identification and quantitative 
determination of the content of amlodipine were performed 
using above methods of analysis of amlodipine. Depending on 
the weight of the organs or f luids under investigation, the vol-
umes of the extractants was changed. It is established that the 
highest amount of amlodipine was found in the stomach and 
intestine with the content, which is typical for acute poisoning. 
Less amount of amlodipine is found in the liver, kidneys and 
urine – organs and liquids that provide active detoxification of 
the body. According to the results of the research, it was found 
that in case of lethal poisoning, amlodipine for forensic toxi-
cological studies should be carried out in urine, stomach with 
contents, intestine with contents, liver, spleen and kidneys. 
The developed methods can be proposed for introduction into 
the practice of the Bureau of Forensic Medical Examination, 
toxicological centers.
4. Discussion
The results of research are important for forensic toxico-
logical analysis, since in literature there are limited data on the 
distribution of amlodipine in the poisoned animal bodies that 
do not have a systematic character [10]. According to the data 
of Shormanov V. K. and Kvachakhiya L. L. for the analysis of 
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amlodipine in the organs of rats were used extractions with 
acetone, purification of extracts in a column with silica gel 
160 μm with eluent-ethanol-hexane (7:3). These methods are 
characterized by significant losses of matter during isolation 
and duration of analysis. The result of using these techniques 
is the selection of a very limited number of organs and fluids 
recommended for forensic toxicology analysis. Despite the use 
of highly sensitive methods for identification and quantification 
(TLC, GC/MS and UV spectrophotometry), only the stomach, 
blood and kidneys can be used in the study. This choice of 
organs does not give an objective picture of poisoning and can 
cause loss of substance during analysis. 
As a result of our studies it was found that in the case of 
lethal poisoning with amlodipine, forensic toxicology analysis 
should be carried out in the urine, stomach with contents, 
in the intestine with contents, liver, spleen and kidneys. The 
choice of important organs and fluids is due to the processes of 
localization of amlodipine and its detoxification. Advantages of 
the obtained results are approbation of the developed methods 
for the analysis of amlodipine in biological objects and the 
use of results in the selection of organs and fluids for forensic 
toxicological analysis. The choice of organs and liquids with 
the maximum content of amlodipine allows to identify and 
to determine the substance in native form in the presence of 
biogenic impurities. Disadvantages – the results of the study 
were obtained on animals, therefore it is important to test the 
analysis methods on the organs and fluids of people who died 
in the fatal poisoning of amlodipine.
The results of the study can be recommended for the use in 
the practice of forensic toxicologists in the study of cadaveric 
material. It is planned to develop tandem methods of high-per-
formance liquid chromatography and gas chromatography with 
mass spectrometry for the analysis of amlodipine and its metab-
olites in animal organs and cadaveric material.
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